Purple Biotech Ltd.

2.69
0.01 (0.31%)
At close: Apr 03, 2025, 2:06 PM

Purple Biotech Ltd. Statistics

Share Statistics

Purple Biotech Ltd. has 13.24K shares outstanding. The number of shares has increased by -90.43% in one year.

Shares Outstanding 13.24K
Shares Change (YoY) -90.43%
Shares Change (QoQ) 2.53%
Owned by Institutions (%) 0%
Shares Floating 13.14K
Failed to Deliver (FTD) Shares 306
FTD / Avg. Volume 1.2%

Short Selling Information

The latest short interest is 19.52K, so 0.74% of the outstanding shares have been sold short.

Short Interest 19.52K
Short % of Shares Out 0.74%
Short % of Float 0.76%
Short Ratio (days to cover) 0.43

Valuation Ratios

The PE ratio is -0.11 and the forward PE ratio is -2.1. Purple Biotech Ltd.'s PEG ratio is 0.

PE Ratio -0.11
Forward PE -2.1
PS Ratio 0
Forward PS 0
PB Ratio 0.02
P/FCF Ratio -0.06
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Purple Biotech Ltd..

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.01.

Current Ratio 2.23
Quick Ratio 2.23
Debt / Equity 0.01
Debt / EBITDA -0.03
Debt / FCF -0.01
Interest Coverage -268.41

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-804.44K
Employee Count 9
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -81.03% in the last 52 weeks. The beta is 0.29, so Purple Biotech Ltd.'s price volatility has been higher than the market average.

Beta 0.29
52-Week Price Change -81.03%
50-Day Moving Average 3
200-Day Moving Average 5.13
Relative Strength Index (RSI) 42.79
Average Volume (20 Days) 25.54K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -11.01M
Net Income -7.24M
EBITDA -7.05M
EBIT -7.24M
Earnings Per Share (EPS) -0.21
Full Income Statement

Balance Sheet

The company has 7.4M in cash and 183K in debt, giving a net cash position of 7.22M.

Cash & Cash Equivalents 7.4M
Total Debt 183K
Net Cash 7.22M
Retained Earnings -144.69M
Total Assets 37.04M
Working Capital 4.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.37M and capital expenditures 0, giving a free cash flow of -14.37M.

Operating Cash Flow -14.37M
Capital Expenditures 0
Free Cash Flow -14.37M
FCF Per Share -0.41
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PPBT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for PPBT is $33, which is 1131.3% higher than the current price. The consensus rating is "Buy".

Price Target $33
Price Target Difference 1131.3%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Sep 17, 2024. It was a backward split with a ratio of 1:20.

Last Split Date Sep 17, 2024
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -5.95
Piotroski F-Score 1